Wijdicks, EF (2016 թ․ հոկտեմբերի 27). «Hepatic Encephalopathy». The New England Journal of Medicine. 375 (17): 1660–1670. doi:10.1056/NEJMra1600561. PMID27783916.
Khan S, Tudur Smith C, Williamson P, Sutton R (2006). «Portosystemic shunts versus endoscopic therapy for variceal rebleeding in patients with cirrhosis». Cochrane Database Syst Rev (4): CD000553. doi:10.1002/14651858.CD000553.pub2. PMID17054131.
Saab S, Nieto JM, Lewis SK, Runyon BA (2006). «TIPS versus paracentesis for cirrhotic patients with refractory ascites». Cochrane Database Syst Rev (4): CD004889. doi:10.1002/14651858.CD004889.pub2. PMID17054221.
Gluud, Lise Lotte; Vilstrup, Hendrik; Morgan, Marsha Y. (2016 թ․ ապրիլի 18). «Non-absorbable disaccharides versus placebo/no intervention and lactulose versus lactitol for the prevention and treatment of hepatic encephalopathy in people with cirrhosis». The Cochrane Database of Systematic Reviews. 4: CD003044. doi:10.1002/14651858.CD003044.pub3. ISSN1469-493X. PMID27089005.
Goh, Ee Teng; Stokes, Caroline S.; Sidhu, Sandeep S.; Vilstrup, Hendrik; Gluud, Lise Lotte; Morgan, Marsha Y. (2018 թ․ մայիսի 15). «L-ornithine L-aspartate for prevention and treatment of hepatic encephalopathy in people with cirrhosis». The Cochrane Database of Systematic Reviews. 5: CD012410. doi:10.1002/14651858.CD012410.pub2. ISSN1469-493X. PMID29762873.
Weissenborn K, Ennen JC, Schomerus H, Rückert N, Hecker H (May 2001). «Neuropsychological characterization of hepatic encephalopathy». J. Hepatol. 34 (5): 768–73. doi:10.1016/S0168-8278(01)00026-5. PMID11434627.
Sherlock S, Summerskill WH, White LP, Phear EA (September 1954). «Portal-systemic encephalopathy; neurological complications of liver disease». Lancet. 264 (6836): 453–7. doi:10.1016/S0140-6736(54)91874-7. PMID13193045.
Last PM, Sherlock S (February 1960). «Systemic absorption of orally administered neomycin in liver disease». N. Engl. J. Med. 262 (8): 385–9. doi:10.1056/NEJM196002252620803. PMID14414396.
Boyer JL, Garcia-Tsao G, Groszmann RJ (February 2012). «In Memoriam: Harold O. Conn, M.D.». Hepatology. 55 (2): 658–9. doi:10.1002/hep.25550.
Wijdicks, EF (2016 թ․ հոկտեմբերի 27). «Hepatic Encephalopathy». The New England Journal of Medicine. 375 (17): 1660–1670. doi:10.1056/NEJMra1600561. PMID27783916.
Khan S, Tudur Smith C, Williamson P, Sutton R (2006). «Portosystemic shunts versus endoscopic therapy for variceal rebleeding in patients with cirrhosis». Cochrane Database Syst Rev (4): CD000553. doi:10.1002/14651858.CD000553.pub2. PMID17054131.
Saab S, Nieto JM, Lewis SK, Runyon BA (2006). «TIPS versus paracentesis for cirrhotic patients with refractory ascites». Cochrane Database Syst Rev (4): CD004889. doi:10.1002/14651858.CD004889.pub2. PMID17054221.
Thumburu, KK; Dhiman, RK; Vasishta, RK; Chakraborti, A; Butterworth, RF; Beauchesne, E; Desjardins, P; Goyal, S; Sharma, N; Duseja, A; Chawla, Y (Mar 2014). «Expression of astrocytic genes coding for proteins implicated in neural excitation and brain edema is altered after acute liver failure». Journal of Neurochemistry. 128 (5): 617–27. doi:10.1111/jnc.12511. PMID24164438.
Gluud, Lise Lotte; Vilstrup, Hendrik; Morgan, Marsha Y. (2016 թ․ ապրիլի 18). «Non-absorbable disaccharides versus placebo/no intervention and lactulose versus lactitol for the prevention and treatment of hepatic encephalopathy in people with cirrhosis». The Cochrane Database of Systematic Reviews. 4: CD003044. doi:10.1002/14651858.CD003044.pub3. ISSN1469-493X. PMID27089005.
Goh, Ee Teng; Stokes, Caroline S.; Sidhu, Sandeep S.; Vilstrup, Hendrik; Gluud, Lise Lotte; Morgan, Marsha Y. (2018 թ․ մայիսի 15). «L-ornithine L-aspartate for prevention and treatment of hepatic encephalopathy in people with cirrhosis». The Cochrane Database of Systematic Reviews. 5: CD012410. doi:10.1002/14651858.CD012410.pub2. ISSN1469-493X. PMID29762873.
Weissenborn K, Ennen JC, Schomerus H, Rückert N, Hecker H (May 2001). «Neuropsychological characterization of hepatic encephalopathy». J. Hepatol. 34 (5): 768–73. doi:10.1016/S0168-8278(01)00026-5. PMID11434627.
Summerskill WH, Davidson EA, Sherlock S, Steiner RE (April 1956). «The neuropsychiatric syndrome associated with hepatic cirrhosis and an extensive portal collateral circulation». Q. J. Med. 25 (98): 245–66. PMID13323252.
Sherlock S, Summerskill WH, White LP, Phear EA (September 1954). «Portal-systemic encephalopathy; neurological complications of liver disease». Lancet. 264 (6836): 453–7. doi:10.1016/S0140-6736(54)91874-7. PMID13193045.
Last PM, Sherlock S (February 1960). «Systemic absorption of orally administered neomycin in liver disease». N. Engl. J. Med. 262 (8): 385–9. doi:10.1056/NEJM196002252620803. PMID14414396.
Gluud, Lise Lotte; Vilstrup, Hendrik; Morgan, Marsha Y. (2016 թ․ ապրիլի 18). «Non-absorbable disaccharides versus placebo/no intervention and lactulose versus lactitol for the prevention and treatment of hepatic encephalopathy in people with cirrhosis». The Cochrane Database of Systematic Reviews. 4: CD003044. doi:10.1002/14651858.CD003044.pub3. ISSN1469-493X. PMID27089005.
Goh, Ee Teng; Stokes, Caroline S.; Sidhu, Sandeep S.; Vilstrup, Hendrik; Gluud, Lise Lotte; Morgan, Marsha Y. (2018 թ․ մայիսի 15). «L-ornithine L-aspartate for prevention and treatment of hepatic encephalopathy in people with cirrhosis». The Cochrane Database of Systematic Reviews. 5: CD012410. doi:10.1002/14651858.CD012410.pub2. ISSN1469-493X. PMID29762873.